Coprelotamab Uses, Dosage, Side Effects and more
Coprelotamab is under investigation in clinical trial NCT04170595 (Clinical Study of Recombinant Anti-her2 Humanized Monoclonal Antibody for Injection).
| Trade Name | Coprelotamab |
| Generic | Coprelotamab |
| Coprelotamab Other Names | Coprelotamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
